A Conversation with Loriana Hernandez-Aldama: Engaging the Latino Community in Oncology Trials
Last month, Hernandez-Aldama joined Inato’s Marketing Lead, Laurel Uballez, and Senior DE&I Growth Manager, Atira Goodwin for a conversation on...
Last month, Hernandez-Aldama joined Inato’s Marketing Lead, Laurel Uballez, and Senior DE&I Growth Manager, Atira Goodwin for a conversation on...
This month, in the spirit of giving thanks, our team at Inato reached out to collaborators across our network to hear what they're grateful for.
After listening to and collaborating with our network of community research centers, we’ve created Check Your Fit as a way to inform sites on whether...
Inato Co-Founder and CEO, Kourosh Davarpanah, sat down with fellow industry leaders to address community-based solutions to the barriers disrupting...
How to dramatically accelerate clinical trials and sustain lower costs in complex and competitive environments
Robert M. Wachter, MD is Professor and Chair of the Department of Medicine at the University of California, San Francisco, where he is the Holly...
In an effort to increase patient access to innovative investigational medicines, Sanofi will partner with Inato to connect with community-based sites...
Christophe Massard, MD PhD is a medical oncologist and the department head at Drug Development Department (DITEP) in Paris, France. He is a member of...
On Thursday June 18th between 12:00 - 1:00 pm EST, Inato hosted a discussion on how to secure more clinical trials for your site
In alignment with a mission to broaden clinical trial access worldwide, Inato has seen major growth across its network in 2022.